title: New scale assesses benefits of cancer medicines.
authors.forename: Sanjeet
authors.initials: S
authors.lastname: Bagcchi
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D017326:Clinical Trials, Phase III as Topic; D004363:Drug Utilization; D015507:Drugs, Investigational / Q000494:pharmacology* / Q000627:therapeutic use; D005060:Europe; D006801:Humans; D008495:Medical Oncology / Q000458:organization & administration; D020380:Needs Assessment; D009369:Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D012955:Societies, Medical; D016019:Survival Analysis; D017211:Treatment Failure; D014481:United States
chemical_list: D000970:Antineoplastic Agents; D015507:Drugs, Investigational